Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02635672
Title Phase I Dose Escalation Study for BAY 1251152 in Patients With Advanced Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Age Groups: adult | senior
Covered Countries USA | ESP

No variant requirements are available.